Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Ryman Healthcare Ltd
NZX:RYM
Ryman Healthcare Ltd
NZX:RYM
Price:
1.85
NZD
Market Closed
Market Cap:
NZ$1.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ryman Healthcare Ltd
NZX:RYM
|
NZ |
|
T
|
TC Energy Corp
F:TRS
|
CA |
|
HRnetGroup Ltd
SGX:CHZ
|
SG |
|
Bank of Montreal
TSX:BMO
|
CA |
|
Upland Software Inc
NASDAQ:UPLD
|
US |
|
L
|
LTC Properties Inc
F:LTP
|
US |
|
SSE PLC
F:SCTA
|
UK |
|
Adneo Ltd
ASX:AD1
|
AU |
|
Strategic Elements Ltd
ASX:SOR
|
AU |
|
B
|
Bukit Asam (Persero) Tbk PT
F:TBA
|
ID |
|
Lithium Americas Corp
TSX:LAC
|
CA |
|
Fosun International Ltd
OTC:FOSUY
|
HK |
|
Upstart Holdings Inc
NASDAQ:UPST
|
US |
|
E
|
EnerSys
SWB:FDN
|
US |
|
K
|
Kekrops SA
ATHEX:KEKR
|
GR |
Wall St Price Targets
RYM Price Forecast
Based on 6 analysts
Based on 6 analysts
+55% Upside
from
NZ$1.85
today
Ryman Healthcare Ltd (RYM)’s 12-month stock price forecast through September 2027 has a consensus target of NZ$2.87, implying 55% upside. The forecast is based on price targets from 6 Wall Street analysts.
RYM Analyst Rating
No ratings yet
No ratings yet
Ryman Healthcare Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RYM's stock price target?
Price Target
2.87
NZD
2.87
NZD
According to Wall Street analysts, the average 1-year price target for RYM is 2.87 NZD with a low forecast of 2.59 NZD and a high forecast of 3.68 NZD.
What is the Revenue forecast for Ryman Healthcare Ltd?
Projected CAGR
8%
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Ryman Healthcare Ltd?
Projected CAGR
78%
78%
Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 78%.